DIFFERENTIATED APPROACH IN EVALUATING THE RESPONSE OF IMMUNE SYSTEM TO THE PRESENCE OF M.TUBERCULOSIS WITH DIFFERENT DRUG SUSCEPTIBILITY

Cover Page

Cite item

Full Text

Abstract

The purpose of the study has a comparative study of quantitative and functional state of the immune system cells in patients with infiltrative pulmonary tuberculosis, which is caused by drug-sensitive and drug-resistant disease. The study included 29 patients, of which: from 12 people the disease was caused by drug-sensitive M.tuberculosis, 17 - the causative agent had multidrug resistance and 25 healthy people. We estimated the number of T- (CD45+CD3+) and B-lymphocytes (CD45+CD19+), NK-cells (CD45+CD3CD16+CD56+), T-helper cells (CD3+CD4+), cytotoxic T cells (CD3+CD8+), γδ-T-lymphocytes (CD3brightCD4-), NKT-cells (CD3+CD16+CD56+), activated T-lymphocytes and by the expression of T-helper cells of CD25 and HLA-DR, the probability of apoptosis of CD95 expression, the number of T-reg-cells (CD3+CD4+CD127CD25+) by flow cytometry on Coulter®Epics®XL instrument (Beckman Coulter, USA). Statistical data analysis was performed using Microsoft software, USA (Office Excel 2007) and StatSoft, USA (Statistica For Windows v.6.1.). Established that infiltrative tuberculosis caused by drug-sensitive M.tuberculosis, accompanied by an increase in HLA-DR expression and decrease in CD95 on T-lymphocytes, reducing the amount of B-cells, increased number of NK-cells. Infiltrative tuberculosis caused by M.tuberculosis multidrug resistance, is characterized by the absence of reducing CD95 on T-lymphocytes, a decrease in the population of NKT cells. Immunological criterion for evaluating drug sensitivity M.tuberculosis is the absolute quantity of CD3+HLA-DR+-cells.

About the authors

O. V. Berdugina

Ural Research Institute of Phthisiopulmonology; Ural State Medical University

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

A. V. Ershova

Ural Research Institute of Phthisiopulmonology

Email: noemail@neicon.ru
Russian Federation

References

  1. Warren E., Teskey G., Venketaraman V. Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection. Journal of Clinical Medicine, 2017. 6(2). 1-15.
  2. Petruccioli E., Scriba T. J., Petrone L., Hatherill M., Cirillo D. M., et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur. Respir. J., 2016. 48(6). 1751-1763.
  3. Jasenosky L. D., Scriba T. J., Hanekom W.A, Goldfeld A. E. T cells and adaptive immunity to Myco-bacterium tuberculosis in humans. Immunol Rev, 2015. 264. 74-87.
  4. Moreira-Teixeira L., Redford P. S., Stavropoulos E., Ghilardi N., Maynard C. L., et al. T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection. J Immunol, 2017. 1601340.
  5. Kalo D., Kant S., Srivastava K., Sharma A. K. Assess drug resistance pattern and genetic profile of Myco-bacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and IS 6110 in pulmonary tuberculosis cases. Lung India, 2017. 34. 155-159.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Berdugina O.V., Ershova A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies